Publications by authors named "Brian Till"

Claim this Profile
I
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.
Andrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, Gabriel O Cole, Blythe D Sather, Brian G Till

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia.
Christina Poh, Xueyan Chen, Jenna Voutsinas, Kikkeri Naresh, Jerlin J Dizon, Brian G Till

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.
Carrie Ho, Neena Kennedy, Mengyang Di, Ajay K Gopal, Ryan C Lynch, Brian G Till

Clin Lymphoma Myeloma Leuk· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities to Improve Antibiotic Stewardship, and Identification of Blood Biomarkers Associated with Bacteremia Following CAR-T Cell Therapy.
Sai Kit Ng, Patrick W Flaherty, Melissa Ancheta, Karyn A Tindbaek, Mandeep K Sekhon, Brian G Till

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma.
Ryan C Lynch, Ryan D Cassaday, Stephen D Smith, Andrew J Cowan, Edus H Warren, Brian G Till

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up.
Andrew J Portuguese, Jennifer J Huang, Yein Jeon, Mahnoosh Taheri, Aya Albittar, Brian G Till

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.
Christina Poh, Jenna M Voutsinas, Mazyar Shadman, Ryan C Lynch, Edus H Warren, Brian G Till

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.
Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, Andrew J Cowan, Gabriel O Cole, Brian G Till

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.
Laura Samples, Hossein Sadrzadeh, Matthew J Frigault, Caron A Jacobson, Mehdi Hamadani, Brian G Till

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.
Ivan J Huang, Grace T Baek, Jonathan Cohen, Sirin Khajaviyan, Stephanie Louie, Brian G Till

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of predictive models of early immune effector cell-associated hematotoxicity.
Emily C Liang, Jennifer J Huang, Andrew J Portuguese, Valentín Ortiz-Maldonado, Aya Albittar, Brian G Till

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact and Durability of the Affordable Care Act Medicaid Expansion on Lung Cancer Treatment.
Darshak S Thosani, Brian M Till, Luke T Meredith, Andrew Kalra, Julie A Barta

Ann Thorac Surg Short Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Utilization of Services and Perioperative Outcomes for Lung Cancer Resection.
Darshak S Thosani, Luke T Meredith, Richard West, Brian M Till, Uzma Rahman

Clin Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Elizabeth F Krakow, Michelle Brault, Corinne Summers, Tanya M Cunningham, Melinda A Biernacki, Brian G Till

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Mitchell R Smith, Opeyemi A Jegede, Peter Martin, Brian G Till, Samir S Parekh

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Institutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy.
Shale J Mack, Hamza Rshaidat, Annie Ho, Brian M Till, Micaela L Collins

Ann Thorac Surg Short Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic Variation in the Utilization of Services Surrounding Lung Cancer Resection.
Darshak S Thosani, Luke T Meredith, Richard West, Brian M Till, Uzma Rahman

Ann Thorac Surg Short Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy.
George Mo, Sang Y Lee, David G Coffey, Valentin Voillet, Ilan R Kirsch, Brian G Till

Blood Cancer Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
to: Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies.
David W Woolston, Nathan D Lee, Mazyar Shadman, Elena Latorre-Esteves, Xin Ray Tee, Brian Till

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Cardiac Surgical Volume and Gaps: Trends, Targets, and Way Forward.
Dominique Vervoort, Grace Lee, Hiba Ghandour, Camila R Guetter, Najah Adreak, Brian M Till

Ann Thorac Surg Short Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Nonmalignant Surgical Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules.
Brian M Till, Tyler Grenda, Taylor Tidwell, Baylor Wickes, Christine Shusted

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
Micaela L Collins, Shale J Mack, Gregory L Whitehorn, Brian M Till, Tyler R Grenda

Ann Thorac Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper Hemisternotomy Versus Full Sternotomy for Replacement of the Supracoronary Ascending Aorta and Aortic Valve.
Vishal N Shah, Jose Binongo, Jane Wei, Brian M Till, Colin King

Innovations (Phila)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic.
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Brian G Till

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 chimeric antigen receptor T cells manufactured in absence of CD4 cells exhibit hypofunctional phenotype.
Sang Yun Lee, Dong Hoon Lee, Wei Sun, Francisco Cervantes-Contreras, Ryan S Basom, Brian G Till

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis